U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07905911) titled 'Maximum Lysis on Thromboelastography as a Marker of Systemic Severity in Acute Allergic Reactions' on Oct. 23.
Brief Summary: The purpose of this research is to better understand the mechanisms behind allergic reactions.
Study Start Date: Oct. 23
Study Type: OBSERVATIONAL
Condition:
Allergy
Allergic Reactions
Anaphylaxis
Biomarkers / Blood
Intervention:
DIAGNOSTIC_TEST: Thromboelastogram
Blood test - Thromboelastogram
Recruitment Status: RECRUITING
Sponsor: Mayo Clinic
Information provided by (Responsible Party): Ronna L. Campbell, Mayo Clinic
Disclaimer: Curated by HT Syndication....